EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis of Tricyclic and Tetracyclic Lactone Derivatives of Thieno[2,3-b]pyrazine or Thieno[2,3-b]quinoline: Preliminary Antitumor and Antiparasitic Activity Evaluation

Maria F Martins, Francisco Ribeiro iD, Ana Borges iD, Ricardo C Calhelha iD, Nuno Santarém, Anabela Cordeiro-da-Silva, Maria-João R P Queiroz iD

Molecules · 2025

DOI: 10.3390/molecules30091999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Maria F Martins und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Química, Universidade do Minho (CQ-UM), Campus de Gualtar, 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Antineoplastic Agents, Lactones, Quinolines, Antiparasitic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology (FCT,Portugal), FCT and co-funded through the European Social Fund within the Human Potential Operating, European Comission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tricyclic and tetracyclic lactone derivatives of thieno[2,3-b]pyrazine or thieno[2,3-b]quinoline, and 2H-pyrones were prepared using different methodologies. Pd/Cu-catalyzed Sonogashira coupling using Et3N as a base, of methyl 7-bromothieno[2,3-b]pyrazine-6-carboxylate and (het)arylalkynes to yield the Sonogashira ester products, gave also the corresponding tricyclic lactones as minor products. However, the major products did not cyclize with TFA. Tricyclic lactones were then obtained by a tandem one-pot Sonogashira coupling and 6-endo-dig lactonization of 7-bromothieno[2,3-b]pyrazine-6-carboxylic acid with (het)arylalkynes, in good yields. Halogenated tricyclic lactones were synthesized by halocyclization using CuX and NXS. Tetracyclic lactones were synthesized through a Rh(III)-catalyzed formal [4+2] cycloaddition, between thieno[2,3-b]quinoline-2-carboxylic acid and internal alkynes, triggered by C-H activation, with the carboxylic group acting as a directing group. Using the SRB assay, the antitumor activity of both Sonogashira products and lactones was evaluated across five human cancer cell lines (CaCo-2, MCF-7, AGS, HeLa, NCI-H460). The best-performing compound was a Sonogashira product showing a GI50 < 10 µM in all tumor cell lines and low toxicity in PLP2 cells. Additionally, antiparasitic testing against Trypanosoma brucei and Leishmania infantum revealed some compounds with IC50 < 11 µM, though some level of cytotoxicity was observed in THP-1—derived macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsLactonesQuinolinesAntiparasitic AgentsPyrazinesHumansCell Line, TumorAnimalsMolecular StructureTrypanosoma brucei bruceiDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

2H-pyronesC-H activationSonogashira couplinglactonizationmetal-catalyzed cycloadditionthieno[2,3-b]pyrazinesthieno[2,3-b]quinolines

Substanzen

Antineoplastic AgentsLactonesQuinolinesAntiparasitic AgentsPyrazines

Autor:innen und Institutionen

  • Centro de Química, Universidade do Minho (CQ-UM), Campus de Gualtar, 4710-057 Braga, Portugal.
  • Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
  • Laboratório Associado para a Sustentabilidade e Tecnologia em Regiões de Montanha (SusTEC), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
  • Host-Parasite Interactions, IBMC/I3S, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal.
  • Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.

ORCID-Profile: Francisco Ribeiro, Ana Borges, Ricardo C Calhelha, Maria-João R P Queiroz

Förderung

  • Foundation for Science and Technology (FCT,Portugal)
  • FCT and co-funded through the European Social Fund within the Human Potential Operating
  • European Comission
  • the Portuguese Foundation for Science and Technology (FCT, Portugal) through CQ-UM
  • CIMO
  • SusTEC
  • the European Social Fund within the Human Potential Operating Programme
  • One Health Drugs against Parasitic Vector-Borne Diseases in Europe and Beyond (OneHealthDrugs)

Zitieren

APA

Martins, M. F., Ribeiro, F., Borges, A., Calhelha, R. C., Santarém, N., Cordeiro-da-Silva, A., & Queiroz, M. R. P. (2025). Synthesis of Tricyclic and Tetracyclic Lactone Derivatives of Thieno[2,3-b]pyrazine or Thieno[2,3-b]quinoline: Preliminary Antitumor and Antiparasitic Activity Evaluation. Molecules. https://doi.org/10.3390/molecules30091999

Vancouver

Martins MF, Ribeiro F, Borges A, Calhelha RC, Santarém N, Cordeiro-da-Silva A, et al. Synthesis of Tricyclic and Tetracyclic Lactone Derivatives of Thieno[2,3-b]pyrazine or Thieno[2,3-b]quinoline: Preliminary Antitumor and Antiparasitic Activity Evaluation. Molecules. 2025. doi:10.3390/molecules30091999

BibTeX
@article{Martins2025,
  author = {Martins, Maria F and Ribeiro, Francisco and Borges, Ana and Calhelha, Ricardo C and Santarém, Nuno and Cordeiro-da-Silva, Anabela and Queiroz, Maria-João R P},
  title = {Synthesis of Tricyclic and Tetracyclic Lactone Derivatives of Thieno[2,3-b]pyrazine or Thieno[2,3-b]quinoline: Preliminary Antitumor and Antiparasitic Activity Evaluation},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30091999}
}
Kostenlos starten →